FdaApplication
ANDA 218755
Identifiers
- fda_app_no: ANDA218755
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2025-09-04 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PALIPERIDONE | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE;ORAL |
| PALIPERIDONE | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE;ORAL |
| PALIPERIDONE | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE;ORAL |
| PALIPERIDONE | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE;ORAL |
4 products